Skip to main content
Premium Trial:

Request an Annual Quote

SEngine Precision Medicine: Astrid Margossian

SEngine Precision Medicine has hired Astrid Margossian as chief medical officer. Margossian, a surgeon, medical oncologist, and cancer researcher with MD and PhD degrees, previously established and served as medical director of Baylor College of Medicine's Breast Center Buenos Aires and Breast Cancer Research Biobank, which focuses on biomarker discovery for breast cancer. 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.